Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Jasper Therapeutics, Inc. | Director | Stock Option (right to buy) | 47K | Jun 7, 2023 | Direct | ||
CRISPR Therapeutics AG | CBO & COO | Restricted Stock Units | 12.5K | Aug 16, 2022 | Direct | ||
Dyne Therapeutics, Inc. | Director | Stock Option (right to buy) | 7.22K | Jul 5, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
JSPR | Jasper Therapeutics, Inc. | Jun 7, 2023 | 1 | $0 | 4 | Jun 8, 2023 | Director |
JSPR | Jasper Therapeutics, Inc. | Oct 12, 2022 | 1 | $0 | 4 | Oct 13, 2022 | Director |
CRSP | CRISPR Therapeutics AG | Aug 16, 2022 | 1 | $0 | 4 | Aug 18, 2022 | CBO & COO |
DYN | Dyne Therapeutics, Inc. | Jul 5, 2022 | 1 | $0 | 4 | Jul 6, 2022 | Director |
DYN | Dyne Therapeutics, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 6, 2022 | Director |
JSPR | Jasper Therapeutics, Inc. | Mar 21, 2022 | 1 | $0 | 4 | Mar 23, 2022 | Director |
CRSP | CRISPR Therapeutics AG | Mar 10, 2022 | 6 | -$193K | 4 | Mar 14, 2022 | CBO & COO |
CRSP | CRISPR Therapeutics AG | Feb 18, 2022 | 2 | $0 | 4 | Feb 22, 2022 | CBO & COO |
CRSP | CRISPR Therapeutics AG | Dec 3, 2021 | 3 | -$774K | 4 | Dec 7, 2021 | CBO & COO |
CRSP | CRISPR Therapeutics AG | Oct 15, 2021 | 1 | $0 | 4 | Oct 18, 2021 | CBO & COO |
JSPR | Jasper Therapeutics, Inc. | Sep 24, 2021 | 0 | $0 | 3 | Oct 1, 2021 | Director |
CRSP | CRISPR Therapeutics AG | Sep 10, 2021 | 3 | -$496K | 4 | Sep 14, 2021 | CBO & COO |
DYN | Dyne Therapeutics, Inc. | May 26, 2021 | 1 | $0 | 4 | May 27, 2021 | Director |